Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-Pa Treatment in Acute Ischemic Stroke Patients Associated With Ameliorating Blood-Brain Barrier Damage

Translational Stroke Research - United States
doi 10.1007/s12975-017-0526-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Does the Sex of Acute Stroke Patients Influence the Effectiveness of Rt-Pa?

BMC Neurology
MedicineNeurology
2014English

Corrigendum: Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke

Frontiers in Neurology
Neurology
2018English

Weisheng-Tang Ameliorates Acute Ischemic Brain Damage in Mice by Maintaining Blood-Brain Barrier Integrity

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2019English

Update on the Serum Biomarkers and Genetic Factors Associated With Safety and Efficacy of Rt-Pa Treatment in Acute Stroke Patients

Stroke Research and Treatment
Neurology
2011English

Pentoxifylline in Acute Ischemic Stroke Patients With Blood Hyperviscosity

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2018English

US Geographic Distribution of Rt-Pa Utilization by Hospital for Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2009English

Why Don’t More Patients Receive Intravenous Rt-Pa for Acute Stroke?

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2015English

Sodium Tanshinone IIA Sulfonate Inhibits the Meq, Ul49 and VP22 Expression of Marek’s Disease Virus

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Sodium Tanshinone IIA Sulfonate Protects ARPE-19 Cells Against Oxidative Stress by Inhibiting Autophagy and Apoptosis

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy